Showing results (51-60 of 178) with videos related to
Sort By:
Pageof 18
BMC Medical Informatics and Decision Making|September 14, 2012
Text data extraction for a prospective, research-focused data mart: implementation and validationMonique Hinchcliff, Eric Just, Sofia Podlusky, et al.Frontiers in Immunology|February 13, 2024
Gene expression meta-analysis reveals aging and cellular senescence signatures in scleroderma-associated interstitial lung diseaseMonica M Yang, Seoyeon Lee, Jessica Neely, et al.Journal of Scleroderma and Related Disorders|April 6, 2022
Complementary therapies for patients with systemic sclerosisKimberly Showalter, Aileen Hoffmann, Nicole DeCredico, et al.Fibrogenesis & Tissue Repair|December 25, 2012
Fibrosis in systemic sclerosis: common and unique pathobiologySwati Bhattacharyya, Jun Wei, Warren G Tourtellotte, et al.Experimental Cell Research|January 19, 2008
Connective tissue growth factor/CCN2-null mouse embryonic fibroblasts retain intact transforming growth factor-beta responsivenessYasuji Mori, Monique Hinchcliff, Minghua Wu, et al.Biorxiv : the Preprint Server for Biology|November 21, 2023
Gene Expression Meta-Analysis Reveals Aging and Cellular Senescence Signatures in Scleroderma-associated Interstitial Lung DiseaseMonica M Yang, Seoyeon Lee, Jessica Neely, et al.Trends in Molecular Medicine|March 13, 2019
The Role of Epigenetic Modifications in Systemic Sclerosis: A Druggable TargetJohn Henderson, Joerg Distler, Steven O'ReillyCells|July 26, 2024
The Novel Cytokine Interleukin-41/Meteorin-like Is Reduced in Diffuse Systemic SclerosisPaul Freedman, Bettina Schock, Steven O'ReillySeminars in Immunology|August 8, 2022
Cellular and Molecular Diversity in SclerodermaMonique Hinchcliff, Rolando Garcia-Milian, Stefano Di Donato, et al.Experimental Dermatology|February 26, 2015
Current frontiers in systemic sclerosis pathogenesisMarzena Ciechomska, Jacob van Laar, Steven O'ReillyPageof 18